Symbols / NVNO $10.53 +0.00% enVVeno Medical Corporation

Healthcare • Medical Devices • United States • NCM
NVNO Chart
About

enVVeno Medical Corporation, a clinical-stage medical device company, focuses on the development of bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous disease. The company's lead product is the VenoValve, a replacement venous valve for the treatment of venous chronic venous insufficiency. Its VenoValve implanted into the femoral vein of the patient in an open surgical procedure via a 5-to-6-inch incision in the upper thigh. The company also develops enVVe, a non-surgical and transcatheter-based replacement venous valve system consisting of the enVVe valve, enVVe delivery system, and delivery system accessories. The company was formerly known as Hancock Jaffe Laboratories, Inc. and changed its name to enVVeno Medical Corporation in October 2021. enVVeno Medical Corporation was incorporated in 1999 and is based in Irvine, California.

Fundamentals
Scroll to Statements
Sector Healthcare Industry Medical Devices Market Cap 6.90M
Enterprise Value -20.61M Income -19.47M Sales —
Book/sh 41.36 Cash/sh 43.04 Dividend Yield —
Payout 0.00% Employees — IPO —
P/E — Forward P/E -8.85 PEG —
P/S — P/B 0.25 P/C —
EV/EBITDA 0.99 EV/Sales — Quick Ratio 13.29
Current Ratio 13.58 Debt/Eq 2.58 LT Debt/Eq —
EPS (ttm) -33.06 EPS next Y -1.19 EPS Growth —
Revenue Growth — Earnings 2025-07-31 16:00 ROA -35.06%
ROE -56.21% ROIC — Gross Margin 0.00%
Oper. Margin 0.00% Profit Margin 0.00% Shs Outstand 655.52K
Shs Float 473.92K Short Float 12.38% Short Ratio 4.16
Short Interest — 52W High 196.70 52W Low 8.67
Beta 1.09 Avg Volume 22.13K Volume 41.17K
Target Price — Recom None Prev Close $10.53
Price $10.53 Change 0.00%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
$10.53
Latest analyst target
3. DCF / Fair value
$-252.89
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$10.53
Low
—
High
—
Mean
—
News
RSS: Latest NVNO news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2025-12-11 DUHAY FRANCIS Director — 4,900 $0.36 $1,742
2025-09-15 DUHAY FRANCIS Director — 4,900 $0.83 $4,067
2024-12-31 DUHAY FRANCIS Director — 81,433 $3.07 $249,999
2024-12-31 GRAY ROBERT Director — 3,500 $2.94 $10,290
2024-12-24 SHRIVASTAVA SANJAY Director — 5,400 $2.90 $15,660
2024-12-19 BERMAN ROBERT ANDREW Chief Executive Officer — 12,000 $2.55 $30,600
2024-12-19 JENUSAITIS MATTHEW Director — 9,620 $2.53 $24,339
2024-03-13 ALAVI HAMED Chief Technology Officer — 8,334 $3.59 $29,919
2024-03-13 ALAVI HAMED Chief Technology Officer — 8,334 $6.22 $51,837
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
0.00
0.00
0.00
0.00
Operating Revenue
0.00
0.00
0.00
0.00
Operating Expense
20.90
-12.28%
23.83
-5.59%
25.24
+1.23%
24.93
Research And Development
9.98
-18.52%
12.25
-9.82%
13.58
+37.01%
9.91
Selling General And Administration
10.92
-5.69%
11.58
-0.67%
11.65
-22.39%
15.02
General And Administrative Expense
10.92
-5.69%
11.58
—
—
Salaries And Wages
6.15
-2.20%
6.29
—
—
Other Gand A
3.56
-11.14%
4.01
—
—
Total Expenses
20.90
-12.28%
23.83
-5.59%
25.24
+1.23%
24.93
Operating Income
-20.90
+12.28%
-23.83
+5.59%
-25.24
-1.23%
-24.93
Total Operating Income As Reported
-20.90
+12.28%
-23.83
+5.59%
-25.24
-1.23%
-24.93
EBITDA
-20.41
+12.40%
-23.30
+5.65%
-24.69
-1.17%
-24.41
Normalized EBITDA
-21.14
+15.13%
-24.92
+5.02%
-26.23
-7.04%
-24.51
Reconciled Depreciation
0.49
-7.39%
0.53
-3.30%
0.55
+4.00%
0.53
EBIT
-20.90
+12.28%
-23.83
+5.59%
-25.24
-1.23%
-24.93
Total Unusual Items
0.73
-54.57%
1.62
+4.93%
1.54
+1411.76%
0.10
Total Unusual Items Excluding Goodwill
0.73
-54.57%
1.62
+4.93%
1.54
+1411.76%
0.10
Special Income Charges
—
—
—
0.00
Other Special Charges
—
—
—
—
Net Income
-19.47
+10.76%
-21.82
+7.22%
-23.52
+4.67%
-24.67
Pretax Income
-19.47
+10.76%
-21.82
+7.22%
-23.52
+4.67%
-24.67
Net Non Operating Interest Income Expense
0.69
+77.89%
0.39
+116.11%
0.18
+11.80%
0.16
Net Interest Income
0.69
+77.89%
0.39
+116.11%
0.18
+11.80%
0.16
Interest Income Non Operating
0.69
+77.89%
0.39
+116.11%
0.18
+11.80%
0.16
Interest Income
0.69
+77.89%
0.39
+116.11%
0.18
+11.80%
0.16
Other Income Expense
0.73
-54.57%
1.62
+4.93%
1.54
+1411.76%
0.10
Other Non Operating Income Expenses
—
—
—
—
Gain On Sale Of Security
0.73
-54.57%
1.62
+4.93%
1.54
+1411.76%
0.10
Tax Rate For Calcs
0.00
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-19.47
+10.76%
-21.82
+7.22%
-23.52
+4.67%
-24.67
Net Income From Continuing Operation Net Minority Interest
-19.47
+10.76%
-21.82
+7.22%
-23.52
+4.67%
-24.67
Net Income From Continuing And Discontinued Operation
-19.47
+10.76%
-21.82
+7.22%
-23.52
+4.67%
-24.67
Net Income Continuous Operations
-19.47
+10.76%
-21.82
+7.22%
-23.52
+4.67%
-24.67
Normalized Income
-20.21
+13.78%
-23.44
+6.47%
-25.06
-1.16%
-24.77
Net Income Common Stockholders
-19.47
+10.76%
-21.82
+7.22%
-23.52
+4.67%
-24.67
Diluted EPS
-33.06
+25.76%
-44.53
+33.39%
-66.85
+13.18%
-77.00
Basic EPS
-33.06
+25.76%
-44.53
+33.39%
-66.85
+13.18%
-77.00
Basic Average Shares
0.59
+20.20%
0.49
+39.42%
0.35
+9.54%
0.32
Diluted Average Shares
0.59
+20.20%
0.49
+39.42%
0.35
+9.54%
0.32
Diluted NI Availto Com Stockholders
-19.47
+10.76%
-21.82
+7.22%
-23.52
+4.67%
-24.67
Insurance And Claims
0.61
-6.87%
0.66
—
—
Rent And Landing Fees
0.60
-4.63%
0.63
—
—
Rent Expense Supplemental
0.60
-4.63%
0.63
—
—
Total Other Finance Cost
—
—
—
—
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
29.56
-34.24%
44.95
-7.57%
48.63
+16.74%
41.66
Current Assets
28.83
-34.09%
43.73
-6.80%
46.92
+18.99%
39.44
Cash Cash Equivalents And Short Term Investments
28.21
-34.62%
43.15
-7.02%
46.41
+18.87%
39.04
Cash And Cash Equivalents
3.06
+74.74%
1.75
-51.55%
3.62
-20.53%
4.55
Cash Financial
—
—
—
—
Other Short Term Investments
25.15
-39.26%
41.40
-3.26%
42.79
+24.07%
34.49
Prepaid Assets
—
—
—
—
Other Current Assets
0.61
+5.68%
0.58
+13.70%
0.51
+30.36%
0.39
Total Non Current Assets
0.74
-39.67%
1.22
-28.74%
1.71
-23.06%
2.23
Net PPE
0.70
-40.71%
1.19
-29.27%
1.68
-23.38%
2.19
Gross PPE
2.10
-14.23%
2.45
-11.05%
2.75
-9.63%
3.04
Accumulated Depreciation
-1.39
-10.82%
-1.26
-17.59%
-1.07
-25.91%
-0.85
Properties
—
—
—
0.00
Machinery Furniture Equipment
0.88
+0.57%
0.87
+2.11%
0.85
+1.06%
0.85
Other Properties
1.22
-22.44%
1.57
-16.99%
1.90
-13.75%
2.20
Leases
—
—
—
0.21
Non Current Prepaid Assets
0.03
+0.00%
0.03
+0.00%
0.03
+0.00%
0.03
Other Non Current Assets
—
—
0.03
+0.00%
0.03
Total Liabilities Net Minority Interest
2.43
-12.99%
2.79
+14.78%
2.44
-16.95%
2.93
Current Liabilities
2.12
+1.29%
2.10
+52.81%
1.37
-10.39%
1.53
Payables And Accrued Expenses
0.80
-20.18%
1.01
+135.60%
0.43
-34.10%
0.65
Payables
0.36
-64.41%
1.01
+135.60%
0.43
-34.10%
0.65
Accounts Payable
0.36
-64.41%
1.01
+135.60%
0.43
-34.10%
0.65
Current Accrued Expenses
0.45
0.00
—
0.12
Pensionand Other Post Retirement Benefit Plans Current
0.80
+31.62%
0.60
+26.36%
0.48
+22.25%
0.39
Current Debt And Capital Lease Obligation
0.39
+7.14%
0.36
+7.69%
0.34
+7.64%
0.31
Current Capital Lease Obligation
0.39
+7.14%
0.36
+7.69%
0.34
+7.64%
0.31
Other Current Liabilities
0.13
+10.74%
0.12
-5.47%
0.13
-27.68%
0.18
Total Non Current Liabilities Net Minority Interest
0.31
-55.71%
0.70
-34.21%
1.06
-24.11%
1.40
Long Term Debt And Capital Lease Obligation
0.31
-55.71%
0.70
-34.21%
1.06
-24.11%
1.40
Long Term Capital Lease Obligation
0.31
-55.71%
0.70
-34.21%
1.06
-24.11%
1.40
Stockholders Equity
27.13
-35.65%
42.16
-8.75%
46.20
+19.29%
38.73
Common Stock Equity
27.13
-35.65%
42.16
-8.75%
46.20
+19.29%
38.73
Capital Stock
0.00
0.00
0.00
0.00
Common Stock
0.00
0.00
0.00
0.00
Preferred Stock
0.00
0.00
0.00
0.00
Share Issued
0.66
+30.93%
0.50
+31.68%
0.38
+40.59%
0.27
Ordinary Shares Number
0.66
+30.93%
0.50
+31.68%
0.38
+40.59%
0.27
Additional Paid In Capital
198.46
+2.29%
194.01
+10.09%
176.24
+21.33%
145.25
Retained Earnings
-171.33
-12.82%
-151.85
-16.78%
-130.04
-22.08%
-106.52
Total Equity Gross Minority Interest
27.13
-35.65%
42.16
-8.75%
46.20
+19.29%
38.73
Total Capitalization
27.13
-35.65%
42.16
-8.75%
46.20
+19.29%
38.73
Working Capital
26.70
-35.87%
41.64
-8.59%
45.55
+20.17%
37.91
Invested Capital
27.13
-35.65%
42.16
-8.75%
46.20
+19.29%
38.73
Total Debt
0.70
-34.21%
1.06
-24.11%
1.40
-18.30%
1.72
Capital Lease Obligations
0.70
-34.21%
1.06
-24.11%
1.40
-18.30%
1.72
Net Tangible Assets
27.13
-35.65%
42.16
-8.75%
46.20
+19.29%
38.73
Tangible Book Value
27.13
-35.65%
42.16
-8.75%
46.20
+19.29%
38.73
Current Notes Payable
—
—
—
—
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-15.57
+7.54%
-16.84
+10.71%
-18.86
-20.74%
-15.62
Cash Flow From Continuing Operating Activities
-15.57
+7.54%
-16.84
+10.71%
-18.86
-20.74%
-15.62
Net Income From Continuing Operations
-19.47
+10.76%
-21.82
+7.22%
-23.52
+4.67%
-24.67
Depreciation Amortization Depletion
0.49
-7.39%
0.53
-3.30%
0.55
+4.00%
0.53
Depreciation
0.49
-7.39%
0.53
-3.30%
0.55
+4.00%
0.53
Depreciation And Amortization
0.49
-7.39%
0.53
-3.30%
0.55
+4.00%
0.53
Other Non Cash Items
—
—
—
-0.29
Stock Based Compensation
3.42
-17.41%
4.14
-20.30%
5.20
-42.23%
8.99
Operating Gains Losses
—
—
—
—
Unrealized Gain Loss On Investment Securities
0.39
+1677.27%
0.02
+104.70%
-0.47
-855.10%
-0.05
Gain Loss On Sale Of PPE
—
—
—
—
Change In Working Capital
-0.40
-236.55%
0.29
+147.08%
-0.62
-46.67%
-0.42
Change In Prepaid Assets
-0.03
+52.86%
-0.07
+41.18%
-0.12
-108.77%
-0.06
Change In Payables And Accrued Expense
0.00
-99.86%
0.70
+481.42%
-0.18
-150.68%
-0.07
Change In Accrued Expense
—
—
0.04
+123.60%
-0.16
Change In Payable
—
—
-0.22
-351.14%
0.09
Change In Account Payable
—
—
-0.22
-351.14%
0.09
Change In Other Current Liabilities
-0.36
-7.69%
-0.34
-7.64%
-0.31
-8.28%
-0.29
Investing Cash Flow
15.86
+1087.72%
1.33
+116.97%
-7.87
+77.23%
-34.55
Cash Flow From Continuing Investing Activities
15.86
+1087.72%
1.33
+116.97%
-7.87
+77.23%
-34.55
Net PPE Purchase And Sale
-0.01
+86.49%
-0.04
-12.12%
-0.03
+71.30%
-0.12
Purchase Of PPE
-0.01
+86.49%
-0.04
-12.12%
-0.03
+71.30%
-0.12
Capital Expenditure
-0.01
+86.49%
-0.04
-12.12%
-0.03
+71.30%
-0.12
Net Investment Purchase And Sale
15.86
+1056.05%
1.37
+117.51%
-7.83
+77.25%
-34.44
Purchase Of Investment
-46.02
+17.18%
-55.57
+1.69%
-56.52
-17.44%
-48.13
Sale Of Investment
61.88
+8.68%
56.94
+16.95%
48.69
+255.68%
13.69
Financing Cash Flow
1.02
-92.50%
13.64
-47.12%
25.79
0.00
Cash Flow From Continuing Financing Activities
1.02
-92.50%
13.64
-47.12%
25.79
0.00
Net Issuance Payments Of Debt
—
—
—
—
Issuance Of Debt
—
—
—
—
Long Term Debt Issuance
—
—
—
—
Net Long Term Debt Issuance
—
—
—
—
Net Common Stock Issuance
0.78
-94.25%
13.59
-47.30%
25.79
0.00
Proceeds From Stock Option Exercised
0.24
+423.91%
0.05
0.00
0.00
Changes In Cash
1.31
+170.26%
-1.87
-99.57%
-0.94
+98.14%
-50.17
Beginning Cash Position
1.75
-51.55%
3.62
-20.53%
4.55
-91.68%
54.73
End Cash Position
3.06
+74.74%
1.75
-51.55%
3.62
-20.53%
4.55
Free Cash Flow
-15.57
+7.72%
-16.88
+10.67%
-18.89
-20.06%
-15.73
Interest Paid Supplemental Data
—
—
—
—
Income Tax Paid Supplemental Data
—
—
—
0.00
Common Stock Issuance
0.78
-94.25%
13.59
-47.30%
25.79
0.00
Issuance Of Capital Stock
0.78
-94.25%
13.59
-47.30%
25.79
0.00
Net Preferred Stock Issuance
—
—
—
—
Preferred Stock Issuance
—
—
—
—
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category